Article
Cystic fibrosis-related kidney disease-emerging morbidity and disease modifier.
Pediatric nephrology (Berlin, Germany) - 1 Dec 2025
Hart Merrill, Kumar Manish, Goswami Himanshu Ballav, Harris William Tom, Skopelja-Gardner Sladjana, Swiatecka-Urban Agnieszka
Abstract excerpt
Cystic fibrosis (CF) is a life-shortening multisystem disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, causing the most devastating phenotypes in the airway and pancreas. Significant advances in treatment for CF lung disease, including the expanded use of high-efficiency modulator therapies (HEMT) such as Trikafta, have dramatically increased both quality of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
